Ann Pediatr Endocrinol Metab.  2014 Dec;19(4):184-190. 10.6065/apem.2014.19.4.184.

Endocrine disorders and the neurologic manifestations

• Yu J

• KMID: 1769350
• DOI: http://doi.org/10.6065/apem.2014.19.4.184

Abstract

The nervous system and the endocrine system are closely interrelated and both involved intimately in maintaining homeostasis. Endocrine dysfunctions may lead to various neurologic manifestations such as headache, myopathy, and acute encephalopathy including coma. It is important to recognize the neurologic signs and symptoms caused by the endocrine disorders while managing endocrine disorders. This article provides an overview of the neurologic manifestations found in various endocrine disorders that affect pediatric patients. It is valuable to think about 'endocrine disorder' as a cause of the neurologic manifestations. Early diagnosis and treatment of hormonal imbalance can rapidly relieve the neurologic symptoms. Better understanding of the interaction between the endocrine system and the nervous system, combined with the knowledge about the pathophysiology of the neurologic manifestations presented in the endocrine disorders might allow earlier diagnosis and better treatment of the endocrine disorders.

Keyword

Endocrine system diseases; Neurologic manifestations; Child

MeSH Terms

Child
Coma
Diagnosis
Early Diagnosis
Endocrine System
Endocrine System Diseases
Headache
Homeostasis
Humans
Muscular Diseases
Nervous System
Neurologic Manifestations*

Reference

1. Low MJ. Neuroendocrinology. In : Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Williams textbook of endocrinology. 12th ed. Philadelphia: Elsevier/Saunders;2011. p. 103–174.

2. Parks JS, Felner EI. Hormones of the hypothalamus and pituitary. In : Kliegman RM, Stanton BF, St Geme JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier/Saunders;2011. p. 1876.

3. Fenichel GM. Clinical pediatric neurology: a signs and symptoms approach. 4th ed. Philadelphia: W.B. Saunders;2001.

4. Sheldon CA, Kwon YJ, Liu GT, McCormack SE. An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics. Pediatr Res. 24. 11. 2014; [Epub]. http://dx.doi:10.1038/pr.2014.188.

5. Park E, Abraham MK. Altered mental status and endocrine diseases. Emerg Med Clin North Am. 2014; 32:367–378. PMID: 24766938.

6. Boveroux P, Bonhomme V, Boly M, Vanhaudenhuyse A, Maquet P, Laureys S. Brain function in physiologically, pharmacologically, and pathologically altered states of consciousness. Int Anesthesiol Clin. 2008; 46:131–146. PMID: 18617821.

7. Taylor DA, Ashwal S. Impairment of consciousness and coma. In : Swaiman KF, Ashwal S, Ferriero DM, Schor NF, editors. Swaiman's pediatric neurology. 5th ed. [Edinburgh]: Elsevier Saunders;2012. p. 1063–1067.

8. Sharma S, Kochar GS, Sankhyan N, Gulati S. Approach to the child with coma. Indian J Pediatr. 2010; 77:1279–1287. PMID: 20830533.

9. Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008; 93:1541–1552. PMID: 18270259.

10. Nyenwe EA, Kitabchi AE. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract. 2011; 94:340–351. PMID: 21978840.

11. Zeitler P, Haqq A, Rosenbloom A, Glaser N. Drugs and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment. J Pediatr. 2011; 158:9–14. 14.e1–14.e2. PMID: 21035820.

12. Papi G, Corsello SM, Pontecorvi A. Clinical concepts on thyroid emergencies. Front Endocrinol (Lausanne). 2014; 5:102. PMID: 25071718.

13. Arsos G. Unexpected diagnosis of thyroid storm in a young child referred for urgent lung perfusion imaging. Clin Nucl Med. 2013; 38:661–663. PMID: 23797220.

14. Vasconcellos E, Pina-Garza JE, Fakhoury T, Fenichel GM. Pediatric manifestations of Hashimoto's encephalopathy. Pediatr Neurol. 1999; 20:394–398. PMID: 10371389.

15. Yu HJ, Lee J, Seo DW, Lee M. Clinical manifestations and treatment response of steroid in pediatric Hashimoto encephalopathy. J Child Neurol. 2013; 29:938–942. PMID: 24056154.

16. Chang JS, Chang TC. Hashimoto's encephalopathy: report of three cases. J Formos Med Assoc. 2014; 113:862–866. PMID: 25443353.

17. Sharma V, Borah P, Basumatary LJ, Das M, Goswami M, Kayal AK. Myopathies of endocrine disorders: a prospective clinical and biochemical study. Ann Indian Acad Neurol. 2014; 17:298–302. PMID: 25221399.

18. Kruse K. Myopathies in endocrine disorders. Monatsschr Kinderheilkd. 1984; 132:581–586. PMID: 6384765.

19. Edvardsson B, Persson S. Subclinical hypothyroidism presenting with gait abnormality. Neurologist. 2010; 16:115–116. PMID: 20220447.

20. Bridges N. What is the value of growth hormone therapy in Prader Willi syndrome? Arch Dis Child. 2014; 99:166–170. PMID: 24162007.

21. Rodrigues F, Grenha J, Ortez C, Nascimento A, Morte B, M-Belinchón M, et al. Hypotonic male infant and MCT8 deficiency- a diagnosis to think about. BMC Pediatr. 2014; 14:252. PMID: 25284458.

22. Webb SM, de Andres-Aguayo I, Rojas-Garcia R, Ortega E, Gallardo E, Mestron A, et al. Neuromuscular dysfunction in adult growth hormone deficiency. Clin Endocrinol (Oxf). 2003; 59:450–458. PMID: 14510907.

23. Schweizer R, Martin DD, Schonau E, Ranke MB. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition. J Clin Endocrinol Metab. 2008; 93:2978–2983. PMID: 18505766.

24. Reus L, Pillen S, Pelzer BJ, van Alfen-van der Velden JA, Hokken-Koelega AC, Zwarts M, et al. Growth hormone therapy, muscle thickness, and motor development in Prader-Willi syndrome: an RCT. Pediatrics. 2014; 134:e1619–e1627. PMID: 25422026.

25. Webb EA, O'Reilly MA, Clayden JD, Seunarine KK, Chong WK, Dale N, et al. Effect of growth hormone deficiency on brain structure, motor function and cognition. Brain. 2012; 135(Pt 1):216–227. PMID: 22120144.

26. Kim YJ, Cheon CK. Prader-Willi syndrome: a single center's experience in Korea. Korean J Pediatr. 2014; 57:310–316. PMID: 25114691.

27. Faustino LC, Ortiga-Carvalho TM. Thyroid hormone role on cerebellar development and maintenance: a perspective based on transgenic mouse models. Front Endocrinol (Lausanne). 2014; 5:75. PMID: 24904526.

28. Piana RL, Vanasse M, Brais B, Bernard G. Myelination delay and Allan-Herndon-Dudley syndrome caused by a novel mutation in the SLC16A2 gene. J Child Neurol. 07. 11. 2014; [Epub]. http://dx.doi.org/10.1177/0883073814555189.

29. Salpietro V, Polizzi A, Di Rosa G, Romeo AC, Dipasquale V, Morabito P, et al. Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications. Int J Endocrinol. 2014; 2014:282489. PMID: 25276129.

30. Bergamaschi R, Livieri C, Uggetti C, Candeloro E, Egitto MG, Pichiecchio A, et al. Brain white matter impairment in congenital adrenal hyperplasia. Arch Neurol. 2006; 63:413–416. PMID: 16540460.

31. Mnif MF, Kamoun M, Mnif F, Charfi N, Kallel N, Rekik N, et al. Brain magnetic resonance imaging findings in adult patients with congenital adrenal hyperplasia: increased frequency of white matter impairment and temporal lobe structures dysgenesis. Indian J Endocrinol Metab. 2013; 17:121–127. PMID: 23776864.

32. Nass R, Heier L, Moshang T, Oberfield S, George A, New MI, et al. Magnetic resonance imaging in the congenital adrenal hyperplasia population: increased frequency of white-matter abnormalities and temporal lobe atrophy. J Child Neurol. 1997; 12:181–186. PMID: 9130092.

33. Ghetti S, Lee JK, Sims CE, Demaster DM, Glaser NS. Diabetic ketoacidosis and memory dysfunction in children with type 1 diabetes. J Pediatr. 2010; 156:109–114. PMID: 19833353.

34. Taylor M, Couto-Silva AC, Adan L, Trivin C, Sainte-Rose C, Zerah M, et al. Hypothalamic-pituitary lesions in pediatric patients: endocrine symptoms often precede neuroophthalmic presenting symptoms. J Pediatr. 2012; 161:855–863. PMID: 22727865.

35. Rose SR, Auble BA. Endocrine changes after pediatric traumatic brain injury. Pituitary. 2012; 15:267–275. PMID: 22057966.

36. Acerini CL, Tasker RC, Bellone S, Bona G, Thompson CJ, Savage MO. Hypopituitarism in childhood and adolescence following traumatic brain injury: the case for prospective endocrine investigation. Eur J Endocrinol. 2006; 155:663–669. PMID: 17062881.

37. Tonner DR, Schlechte JA. Neurologic complications of thyroid and parathyroid disease. Med Clin North Am. 1993; 77:251–263. PMID: 8419721.

38. Shaw C, Shaw P. Kocher-Debre-Semelaigne syndrome: hypothyroid muscular pseudohypertrophy-a rare report of two cases. Case Rep Endocrinol. 2012; 2012:153143. PMID: 22934196.

39. Agrawal L, Habib Z, Emanuele NV. Neurologic disorders of mineral metabolism and parathyroid disease. Handb Clin Neurol. 2014; 120:737–748. PMID: 24365349.

40. Eyal O, Oren A, Juppner H, Somech R, De Bellis A, Mannstadt M, et al. Hypoparathyroidism and central diabetes insipidus: in search of the link. Eur J Pediatr. 2014; 173:1731–1734. PMID: 25367057.

41. Damiani D, Aguiar CH, Bueno VS, Montenegro FL, Koch VH, Cocozza AM, et al. Primary hyperparathyroidism in children: patient report and review of the literature. J Pediatr Endocrinol Metab. 1998; 11:83–86. PMID: 9642634.

42. Hsieh S, White PC. Presentation of primary adrenal insufficiency in childhood. J Clin Endocrinol Metab. 2011; 96:E925–E928. PMID: 21470994.

43. Choudhary S, Alam A, Dewan V, Yadav D, Dubey NK. An unusual presentation of Addison's disease: a case report. Clin Pediatr Endocrinol. 2011; 20:57–60. PMID: 23926396.

44. Hinz LE, Kline GA, Dias VC. Addison's disease in evolution: an illustrative case and literature review. Endocr Pract. 2014; 20:e176–e179. PMID: 25100373.

45. Hebbar KB, Stockwell JA, Leong T, Fortenberry JD. Incidence of adrenal insufficiency and impact of corticosteroid supplementation in critically ill children with systemic inflammatory syndrome and vasopressordependent shock. Crit Care Med. 2011; 39:1145–1150. PMID: 21336126.

46. Menon K, Ward RE, Lawson ML, Gaboury I, Hutchison JS, Hébert PC, et al. A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med. 2010; 182:246–251. PMID: 20299532.

47. Santos L. Stress response in critical illness. Curr Probl Pediatr Adolesc Health Care. 2013; 43:264–272. PMID: 24295607.

48. Gunst J, Van den Berghe G. Blood glucose control in the intensive care unit: benefits and risks. Semin Dial. 2010; 23:157–162. PMID: 20525106.

49. Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014; 37:3124–3131. PMID: 25342831.

50. Ho J, Mah JK, Hill MD, Pacaud D. Pediatric stroke associated with new onset type 1 diabetes mellitus: case reports and review of the literature. Pediatr Diabetes. 2006; 7:116–121. PMID: 16629718.

51. Mulder L, Onur O, Kleis L, Borders H, Cemeroglu AP. Atypical neurologic presentations of new onset type 1 diabetes mellitus in pediatric age group: a report of five unusual cases and review of the literature. J Pediatr Endocrinol Metab. 2014; 27:749–756. PMID: 24526607.

52. Nelson D, Mah JK, Adams C, Hui S, Crawford S, Darwish H, et al. Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2006; 7:305–310. PMID: 17212597.